Application of Clinical Pharmacy Monitoring in Patients with Advanced Lung Cancer with Adverse Reactions Caused by Anlotinib Hydrochloride

WANG Mei-xiang; GUO Wei-hua; ZHANG Qi-xiang

doi:10.3969/j.issn.1004-5775.2021.23.021

Home>Articles>Application of Clinical Pharmacy Monitoring in Patients with Advanced Lung Cancer with Adverse Reactions Caused by Anlotinib Hydrochloride

DOI: 10.3969/j.issn.1004-5775.2021.23.021

Application of Clinical Pharmacy Monitoring in Patients with Advanced Lung Cancer with Adverse Reactions Caused by Anlotinib Hydrochloride

WANG Mei-xiang

GUO Wei-hua

ZHANG Qi-xiang

Machine-generated Keywords：

Publication Date：2021-12-15

Online Publishing Date：2025-08-15(First online date of this platform, not the publication date of the document)

Pages：3( 2515-2517 )

HEILONG MEDICAL JOURANL

ISSN：1004-5775

Year, Vol.(Issue)：2021,45(23)